A recent study examining the websites of 30 DTC genomics firms found that many do not follow international recommendations for disclosing information to customers.
The company said the investments will support growth in its AncestryDNA genetic genealogy offering.
Consumer genetics companies field law enforcement requests, the Associated Press reports.
At the New York Times, Marie Tae McDermott writes about her experience with genetic testing as an adoptee.
Researchers from Brigham and Women's and Harvard surveyed more than 1,600 new customers of 23andMe or Pathway Genomics in the US, of whom 80 were adopted.
In PLOS this week: researchers trace inherited cancer syndrome to a German couple born in the 1700s, loci involved in exceptional longevity, and more.
Four families from across the US have an inherited cancer syndrome that researchers traced to a couple that emigrated from Germany in the 1700s.
As the number of people genotyped looks set to pass 3 million this year, third-party tools providers have worked to improve usability, add features, and upgrade their servers for scalability.
The availability of consumer genomics services has also made it possible for adoptees to bypass state adoption laws, many of which restrict access to their records.
23andMe has seen a rebound in its ancestry testing business, and hopes that it will be able to return health information to US customers by the year end.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.